RP
MDXG icon

Rowlandmiller & Partners’s MiMedx Group MDXG Stock Holding History

Rowlandmiller & Partners’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,000
Closed -$125K – 170
2021
Q2 		$125K Hold
10,000
– – 0.03% 165
2021
Q1 		$103K Buy
+10,000
New +$96.6K 0.03% 167
2018
Q4 		– Sell
-184,923
Closed -$1.14M – 133
2018
Q3 		$1.14M Hold
184,923
– – 0.41% 56
2018
Q2 		$1.18M Hold
184,923
– – 0.46% 55
2018
Q1 		$1.3M Hold
184,923
– – 0.52% 51
2017
Q4 		$2.34M Sell
184,923
-29,077
-14% -$355K 0.92% 38
2017
Q3 		$2.55M Buy
214,000
+9,000
+4% +$133K 1.06% 35
2017
Q2 		$3.04M Buy
+205,000
New +$2.74M 1.29% 32

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Rowlandmiller & Partners's MDXG Position: Q3 2021 in Review

Rowlandmiller & Partners sold out of MiMedx Group (MDXG) in Q3 2021, closing a stake of 10,000 shares — an estimated $125K sold.

Rowlandmiller & Partners first reported a position in MDXG in Q2 2017 and held it in 8 quarters. The position peaked at $3.04M in Q2 2017. 142 funds tracked by Wall St. Rank hold MDXG as of Q3 2021.

  • Rowlandmiller & Partners reported no remaining MiMedx Group position as of Q3 2021 after selling out during the quarter.
  • Rowlandmiller & Partners sold 10,000 MiMedx Group shares in Q3 2021, an estimated $125K.
  • Rowlandmiller & Partners first reported a position in MiMedx Group in Q2 2017 and held it in 8 quarters.
  • Rowlandmiller & Partners's MiMedx Group position peaked at $3.04M in Q2 2017.
  • 142 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2021.

Based on Rowlandmiller & Partners's 13F filing for Q3 2021, filed 8 Nov 2021.